Avantor, Inc. ($AVTR) Stock Forecast: Up 5.8% Today

What is Avantor, Inc.?

Avantor Inc (AVTR) operates in the biopharma, healthcare, education, and government sectors, offering products and services. The stock showed strong bullish momentum today.

Why is Avantor, Inc. going up?

AVTR stock is up 5.8% on Jun 25, 2026 14:16

• The technical analysis of AVTR points to a "Sell" signal based on various indicators like MACD, RSI, and moving averages. Despite this, the stock witnessed a bullish upturn, which might have surprised some market participants.
• An executive of Avantor, Corey Walker, made a tax-related disposition where shares were used to cover RSU taxes, potentially indicating confidence in the company's future performance and boosting investor sentiment.
• An investigation into possible corporate misconduct involving Avantor and its officers/directors initially created uncertainty. However, the stock's bullish movement suggests that investors could be hopeful about the company's ability to address any accusations effectively.
• Although Wolfe Research issued an "Underperform" rating, expressing concerns about stagnant sales, margin compression, and competitive setbacks, investors seem to be focusing on Avantor's long-term growth potential, especially if the company successfully overcomes the mentioned challenges.

AVTR Price Chart

AVTR Technical Analysis

AVTR News

Avantor Inc (AVTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Avantor Inc (AVTR), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. The analysis suggests a "Sell" signal based on aggregated indicators, with specific breakdowns for MACD, RSI, and moving averages. It also includes FAQs explaining technical ratings and moving averages.

https://www.tradingkey.com/markets/stocks/nasdaq-avtr/technical

Avantor (AVTR) executive has shares withheld to cover RSU taxes

Avantor, Inc. executive Corey Walker, President of VWR Distribution & Services, had 3,010 shares of Common Stock withheld at $9.58 per share to cover tax obligations related to vesting Restricted Stock Units (RSUs). This transaction was a tax-related disposition, not an open-market sale, and resulted in Walker directly holding 384,535 Avantor common shares afterward. The Form 4 filing details this transaction, indicating it was specifically for tax withholding purposes.

https://www.stocktitan.net/sec-filings/AVTR/form-4-avantor-inc-insider-trading-activity-cba564d511b0.html

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Avantor, Inc. (NYSE:AVTR) and its officers/directors. The firm is encouraging investors who purchased Avantor securities before March 5, 2024, and still hold them, to participate in the investigation by visiting their website or contacting them directly. The investigation aims to restore investor capital and ensure corporate accountability.

https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-initiates-an-investigation-in-1179587

What Avantor (AVTR)'s Wolfe Underperform Call Means For Shareholders

Wolfe Research initiated coverage on Avantor (AVTR) with an "Underperform" rating, citing flat sales, margin pressure, competitive losses in its VWR distribution business, and concerns about its product strategy and reliance on acquisitions. Avantor's Q1 2026 results showed flat sales and decreased net income, aligning with Wolfe's concerns. The report suggests investors should closely examine the potential for sustained margin compression and the company's ability to stabilize its core business and earnings power.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/what-avantor-avtrs-wolfe-underperform-call-means-for-shareho

What Avantor (AVTR)'s Wolfe Underperform Call Means For Shareholders

Wolfe Research initiated coverage on Avantor (AVTR) with an "Underperform" rating, citing flat sales, margin pressure, and competitive losses in its VWR distribution business. The report challenges Avantor's growth and margin prospects, especially given its recent Q1 2026 results that showed stagnant revenue and declining net income. Investors are prompted to reassess Avantor’s ability to improve its earnings amid these concerns, despite some analyst forecasts predicting future revenue and earnings growth.

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-avtr/avantor/news/what-avantor-avtrs-wolfe-underperform-call-means-for-shareho/amp

Trending Today

McCormick & Company Incorporated ($MKC) Stock Forecast: Up 5.5% Today

Stryker Corporation ($SYK) Stock Forecast: Up 5.4% Today

Salesforce.com Inc ($CRM) Stock Forecast: Up 5.3% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Down 6.7% Today

Cisco Systems Inc. ($CSCO) Stock Forecast: Down 5.0% Today

Fastly Inc. ($FSLY) Stock Forecast: Up 6.0% Today

Robinhood Inc. ($HOOD) Stock Forecast: Up 5.9% Today

Shopify Inc. Class A Subordinate ($SHOP) Stock Forecast: Up 5.4% Today

Caterpillar Inc. ($CAT) Stock Forecast: Down 5.1% Today

Lam Research Corporation ($LRCX) Stock Forecast: Down 5.3% Today

Avantor, Inc. Price History

29.04.2026 - AVTR Stock was up 5.1%

• The bullish movement in AVTR stock today can be attributed to the company's solid Q1 update and reiteration of its 2024 guidance, instilling confidence in investors.
• The increasing interest from institutional investors, as highlighted in recent 13F filings, such as major buyers like Greenhaven Associates and Gotham Asset Management, indicates growing confidence in Avantor's long-term earnings potential, potentially driving the stock higher.
• Despite ongoing investigations into potential corporate wrongdoing, the market seems to be focusing more on the positive fundamentals and institutional interest in Avantor, leading to the bullish movement.
• Analyst sentiment pointing towards a potential 21.39% upside in the healthcare sector for Avantor further adds to the positive outlook for the stock, attracting investors looking for growth opportunities in the sector.

30.03.2026 - AVTR Stock was up 5.4%

• A significant stake by an investor in Avantor suggests confidence in the company's future prospects, potentially improving investor sentiment.
• Avantor's strong Q1 2026 results, attributed to enhanced execution in key segments and the success of its "Revival" transformation program, may have contributed to the positive stock movement.
• Despite challenges with revenue growth and declining margins in recent years, Avantor's reaffirmed full-year guidance and positive earnings call have reassured investors about the company's turnaround efforts, leading to the stock price increase.
• Although flat net sales year-over-year and some financial metric declines were reported in the 10-Q, the company's positive outlook for the year has outweighed these aspects, driving the bullish market movement.

30.03.2026 - AVTR Stock was up 5.6%

• Strong Q1 2026 earnings were reported by Avantor, surpassing expectations with an EPS of $0.17 and revenue of $1.581 billion, leading to a 6.49% surge in premarket trading.
• The company's initiatives under "Revival," which target operational stability and execution improvements, are yielding positive results, particularly within the BMP segment.
• Institutional confidence in Avantor's future growth prospects is highlighted by Vanguard's disclosure of a 5.29% stake in the company.
• Despite concerns regarding stagnant revenue growth over the past five years, Avantor's reiteration of full-year guidance and anticipated organic revenue growth in the latter half of 2026 have reinforced investor confidence, propelling a bullish trend in the stock.

21.04.2026 - AVTR Stock was up 5.1%

• The appointment of Gerard Porreca as Executive Vice President, Quality and Regulatory, reflects Avantor's dedication to improving quality assurance and regulatory compliance, likely contributing to increased investor confidence in the company's future.
• Despite recent concerns regarding declining organic revenue and stagnant revenue growth, Avantor's strategic hire and focus on quality standards could be viewed as a positive step in addressing these challenges and rebuilding market trust.
• The projected growth in the global Cell Culture Media Market, an industry where Avantor holds a significant position, suggests a promising industry outlook driving optimism about the company's potential for future expansion and revenue growth.

24.03.2026 - AVTR Stock was up 5.5%

• The appointment of Ludovic Brellier as the Executive Vice President, Bioscience & Medtech Products, and Chief Transformation Officer has generated positivity around Avantor, signaling a strategic shift towards improving operational performance and implementing company-wide transformation.
• Analysts predict a return to profitability for Avantor this year post the leadership changes and transformation efforts, which likely bolstered investor confidence and contributed to the stock's upward momentum.
• The forthcoming departure of the current EVP, Benoit Gourdier, scheduled by year-end 2026 to assume an integration support role, may be seen as a move to streamline operations and position the company for future growth, further instilling investor optimism in Avantor's potential.
• An investigation into potential corporate misconduct at Avantor before March 5, 2024, initiated by Bronstein, Gewirtz & Grossman, LLC, could have sparked shareholder concerns initially. However, the positive leadership developments and growth strategies appear to have outweighed these apprehensions, driving the bullish market performance.

24.05.2026 - AVTR Stock was up 5.3%

• Despite an investigation into potential corporate wrongdoing by Avantor, Inc., investors seemed focused on other factors influencing the stock.
• The bullish movement could be attributed to a tax-related disposition by Avantor executive Corey Walker, which may have signaled confidence in the company's future prospects.
• A "Underperform" rating by a research firm and concerns about flat sales and margin pressure did not seem to deter investors, possibly indicating optimism about Avantor's ability to address these challenges.
• Positive earnings forecast and revenue growth estimates for Avantor Inc might have also contributed to the bullish sentiment, showing potential for future growth and profitability.

06.04.2026 - AVTR Stock was up 5.2%

• An investigation into potential corporate misconduct by Avantor's executives may have initially caused unease among investors, resulting in a stock price decline over the past year.
• Director Simon Dingemans' recent acquisition of company stock, following Avantor's strong performance in Q1 2026, is likely to have inspired investor confidence and had a positive effect on the stock price.
• The allocation of restricted stock units and stock options to EVP Ludovic Brellier as part of his compensation package may have indicated to the market the company's vision for long-term growth and its dedication to retaining top talent.
• Insider actions, such as the director's purchase of shares on the open market and the EVP's completion of ownership forms, may have additionally increased investor faith in Avantor's leadership and future prospects, contributing to the favorable market movement.

28.04.2026 - AVTR Stock was up 5.9%

• An ongoing investigation into possible corporate wrongdoing by Avantor, Inc. initially brought uncertainty among investors, resulting in a brief period of stagnation or decline in the stock price.
• Interest from institutional investors like Greenhaven Associates and Gotham Asset Management reflects positive sentiment towards Avantor's long-term earnings potential and strategic positioning in the life sciences sector, potentially influencing the bullish movement.
• Analysis indicates a near-term neutral sentiment but suggests a halt in mid and long-term weakness, prompting investors to reevaluate and regain confidence, leading to increased buying activity.
• The upsurge in Avantor's stock today may be attributed to a mix of institutional interest, potential legal challenges, and strategic trading analysis.

28.04.2026 - AVTR Stock was up 10.1%

• The investigation may have initially caused some uncertainty among investors, but the subsequent news of institutional investors like Greenhaven Associates and Gotham Asset Management increasing their positions indicates growing confidence in Avantor's potential, boosting the stock.
• The stock analysis pointing towards a potential 21.39% upside in the healthcare sector could have attracted more investors, further driving the bullish movement.
• Highlighting a risk-reward short setup with significant downside potential might have led to short-term traders covering their positions, contributing to the bullish momentum.
• Overall, the combination of increased institutional interest, positive stock analysis, and short-term trading strategies could have fueled the bullish movement in Avantor's stock today.

08.05.2026 - AVTR Stock was up 5.9%

• Positive cash flow in Q1 2026 and 2025, alongside a robust operating cash flow in 2025, likely increased investor confidence in Avantor's financial stability and growth potential.
• An inquiry into potential corporate misconduct may have caused initial market uncertainty, but the absence of significant negative findings may have eased investor worries, contributing to the upward movement.
• AI-generated trading strategies suggesting a short position on AVTR for the long term may have attracted short-term traders seeking to profit from expected market trends, further boosting the stock.
• In summary, the favorable financial performance, ongoing investigations with no immediate adverse outcomes, and strategic trading guidance could have collectively fueled the positive momentum in Avantor's stock today.

25.05.2026 - AVTR Stock was up 5.8%

• The technical analysis of AVTR points to a "Sell" signal based on various indicators like MACD, RSI, and moving averages. Despite this, the stock witnessed a bullish upturn, which might have surprised some market participants.
• An executive of Avantor, Corey Walker, made a tax-related disposition where shares were used to cover RSU taxes, potentially indicating confidence in the company's future performance and boosting investor sentiment.
• An investigation into possible corporate misconduct involving Avantor and its officers/directors initially created uncertainty. However, the stock's bullish movement suggests that investors could be hopeful about the company's ability to address any accusations effectively.
• Although Wolfe Research issued an "Underperform" rating, expressing concerns about stagnant sales, margin compression, and competitive setbacks, investors seem to be focusing on Avantor's long-term growth potential, especially if the company successfully overcomes the mentioned challenges.

04.05.2026 - AVTR Stock was up 5.2%

• A potential shift in sentiment for AVTR from near and mid-term strength to a weak long-term outlook was suggested, with various trading strategies and a short setup recommendation. This could have sparked interest and buying activity in the stock.
• An investigation into potential corporate wrongdoing by AVTR's officers and/or directors might have initially caused uncertainty and a dip in the stock price. However, the market seems to have shrugged off this news and focused on other positive factors.
• Despite an Underperform rating and concerns over growth and margin challenges, other analyses indicate the stock may be undervalued, especially after surpassing Q1 2026 earnings expectations. This mixed sentiment could have led to increased volatility but ultimately resulted in a bullish movement.
• The appointment of Ludovic Brellier as EVP and Chief Transformation Officer could have instilled confidence in investors regarding Avantor's strategic initiatives and long-term growth prospects, contributing to the bullish momentum in the stock.